NM23 in ovarian cancer: Correlation with clinicopathological and biochemical parameters

Annals of the New York Academy of Sciences

Volumn 784, Issue , 1996, Pages 509-512

  Ferrandina, Gabriella ^a   Scambia, Giovanni ^a   Marone, Maria ^a   Benedetti Panici, Pierluigi ^a   Giannitelli, Cecilia ^a   Pernisco, Stefania ^a   Coronetta, Ferdinando ^a   Mancuso, Salvatore ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; METASTASIS; OVARY CANCER; PATHOLOGY; PROGNOSIS; TUMOR SUPPRESSOR GENE;

EID: 0029975302     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb16271.x     Document Type: Article

References (11)

1. STEEG, P. S., G. BEVILACQUA, I. KOPPER et al. 1988. Evidence for a novel gene associated with a low tumor metastatic potential. J. Natl. Cancer Inst. 80: 200-204.
2. LEONE, A., U. FLATOW, C. RICHTER KING et al. 1991. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 65: 25-35.
3. LEONE, A., U. FLATOW, K. VANHOUTTE et al. 1993. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization, and enzymatic activity. Oncogene 8: 2325-2333.
4. BEVILACQUA, G., M. E. SOBEL, L. A. LIOTTA et al. 1989. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res. 49: 5185-5190.
5. KONISHI, N., S. NAKAOKA, T. TSUZUKI et al. 1993. Expression of nm23-H1 and nm23-H2 proteins in prostate carcinoma. Jpn. J. Cancer Res. 84: 1050-1054.
6. NAKAYAMA, H., W. YASUI, H. YOKOZAKI et al. 1993. Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn. J. Cancer Res. 84: 184-190.
7. LEONE, A., R. C. SEEGER, C. M. HONG et al. 1993. Evidence for nm23 RNA overexpression, DNA amplification, and mutation in aggressive childhood neuroblastomas. Oncogene 8: 855-865.
8. HIGASHIYAMA, M., O. DOI, H. YOKOUCHI et al. 1992. Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adenocarcinoma: lack of prognostic value. Br. J. Cancer 66: 533-536.
9. SAWAN, A., I. LASCU, M. VERON et al. 1994. NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study. J. Pathol. 172: 27-34.
10. SCAMBIA, G., P. BENEDETTI PANICI, F. BATTAGLIA et al. 1992. Significance of epidermal growth factor receptor in advanced ovarian cancer. J. Clin. Oncol. 10: 529-535.
11. MANDAI, M., I. KONISHI, M. KOSHIYAMA et al. 1994. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR c-erbB-2 and c-erbB-3 genes, and sex steroid receptor expression. Cancer Res. 54: 1825-1830.